Index RUT
P/E -
EPS (ttm) -3.79
Insider Own 8.63%
Shs Outstand 104.22M
Perf Week 14.59%
Market Cap 392.91M
Forward P/E -
EPS next Y -0.66
Insider Trans 0.01%
Shs Float 95.22M
Perf Month -17.14%
Income -323.99M
PEG -
EPS next Q -0.46
Inst Own 75.16%
Short Float 12.21%
Perf Quarter -26.80%
Sales 234.04M
P/S 1.68
EPS this Y 20.20%
Inst Trans 13.79%
Short Ratio 6.23
Perf Half Y -52.22%
Book/sh -1.72
P/B -
EPS next Y 57.85%
ROA -61.11%
Short Interest 11.63M
Perf Year -88.62%
Cash/sh 2.44
P/C 1.54
EPS next 5Y 11.60%
ROE -2096.78%
52W Range 3.21 - 37.98
Perf YTD -57.11%
Dividend Est. -
P/FCF -
EPS past 5Y 0.57%
ROI -102.54%
52W High -90.07%
Beta 1.10
Dividend TTM -
Quick Ratio 3.29
Sales past 5Y 815.27%
Gross Margin 62.38%
52W Low 17.45%
ATR (14) 0.31
Dividend Ex-Date -
Current Ratio 3.80
EPS Y/Y TTM 21.27%
Oper. Margin -94.31%
RSI (14) 40.90
Volatility 9.92% 7.11%
Employees 597
Debt/Eq -
Sales Y/Y TTM 76.55%
Profit Margin -138.43%
Recom 1.75
Target Price 14.91
Option/Short Yes / Yes
LT Debt/Eq -
EPS Q/Q 66.08%
Payout -
Rel Volume 0.67
Prev Close 3.80
Sales Surprise 12.37%
EPS Surprise 23.89%
Sales Q/Q 39.82%
Earnings Feb 28 AMC
Avg Volume 1.87M
Price 3.77
SMA20 -4.20%
SMA50 -22.88%
SMA200 -61.18%
Trades
Volume 1,256,107
Change -0.66%
Date
Action
Analyst
Rating Change
Price Target Change
Jan-29-24 Downgrade
Mizuho
Buy → Neutral
$16 → $9
Jan-09-24 Downgrade
Goldman
Buy → Neutral
$30 → $8
Aug-16-23 Upgrade
Exane BNP Paribas
Underperform → Neutral
$20
Oct-11-22 Initiated
Morgan Stanley
Equal-Weight
$27
Sep-22-22 Initiated
Goldman
Buy
$33
Oct-25-21 Downgrade
Wells Fargo
Overweight → Equal Weight
$35 → $17
Oct-15-20 Reiterated
Needham
Buy
$36 → $42
Aug-11-20 Resumed
Mizuho
Buy
$32
Mar-23-20 Downgrade
Goldman
Buy → Neutral
$32 → $15
Dec-02-19 Initiated
Goldman
Buy
Oct-30-19 Upgrade
Wells Fargo
Market Perform → Outperform
$20
Jun-11-19 Initiated
Barclays
Overweight
$28
Feb-15-19 Initiated
Wells Fargo
Market Perform
Feb-14-19 Initiated
H.C. Wainwright
Buy
$25
Jan-29-19 Initiated
Stifel
Buy
$50
Nov-16-18 Upgrade
Guggenheim
Neutral → Buy
Sep-17-18 Downgrade
JMP Securities
Mkt Outperform → Mkt Perform
Apr-20-18 Reiterated
Mizuho
Buy
$54 → $48
Mar-27-18 Initiated
Needham
Buy
$42
Mar-05-18 Initiated
Goldman
Buy
$60
Show Previous Ratings
Today 04:05PM
Apr-12-24 08:00AM
Mar-27-24 04:05PM
Mar-04-24 09:25AM
06:37AM
08:23AM
Loading…
Mar-02-24 08:23AM
Feb-29-24 06:41AM
(Thomson Reuters StreetEvents) +26.15%
Feb-28-24 04:43PM
04:05PM
Feb-21-24 08:01AM
08:00AM
Feb-02-24 08:00AM
Feb-01-24 08:00AM
Jan-08-24 08:00AM
Nov-09-23 07:05PM
09:54AM
Loading…
09:54AM
(Thomson Reuters StreetEvents)
Nov-08-23 07:00PM
04:06PM
04:05PM
Nov-06-23 08:00AM
Nov-01-23 08:00AM
Oct-26-23 08:00AM
Oct-14-23 01:15PM
Sep-19-23 04:18PM
(Investor's Business Daily) -17.31%
09:00AM
Sep-06-23 02:27PM
12:43PM
Aug-29-23 12:43AM
Aug-22-23 10:43AM
08:00AM
04:09AM
Loading…
Aug-21-23 04:09AM
Aug-14-23 04:03PM
(Investor's Business Daily)
08:00AM
Aug-08-23 06:15PM
04:05PM
Aug-03-23 09:19AM
Aug-01-23 08:00AM
Jul-29-23 11:39AM
Jul-13-23 03:00PM
09:35AM
Jun-29-23 06:20AM
Jun-21-23 08:41PM
May-23-23 04:05PM
May-17-23 06:35AM
May-16-23 02:34AM
May-10-23 10:45AM
(Investor's Business Daily)
May-09-23 06:05PM
04:05PM
06:25AM
May-02-23 10:01AM
08:00AM
Apr-18-23 08:41AM
Apr-05-23 08:00AM
Apr-04-23 11:15PM
Mar-30-23 08:00AM
Mar-29-23 05:36AM
Mar-07-23 08:00AM
Mar-03-23 08:11PM
Mar-01-23 10:33AM
(Thomson Reuters StreetEvents) -7.06%
Feb-28-23 07:45PM
04:06PM
04:05PM
Feb-27-23 08:00AM
06:21AM
Feb-24-23 05:10PM
(Investor's Business Daily)
07:48AM
Feb-23-23 08:00AM
Feb-22-23 10:00AM
Feb-21-23 04:05PM
Feb-20-23 10:00AM
Feb-03-23 02:15PM
(Investor's Business Daily)
Feb-02-23 12:00PM
Jan-30-23 10:20AM
Jan-27-23 12:47PM
(American City Business Journals)
Jan-23-23 04:14AM
Jan-09-23 08:00AM
Jan-06-23 06:00PM
Nov-22-22 08:00AM
Nov-17-22 08:00AM
Nov-10-22 05:32AM
(Simply Wall St.) +13.15%
Nov-09-22 08:00AM
Nov-08-22 06:05PM
04:05PM
Nov-04-22 08:00AM
Nov-02-22 10:01AM
Nov-01-22 01:01PM
10:01AM
08:00AM
Oct-24-22 12:02PM
Oct-20-22 08:00AM
Oct-17-22 08:00AM
Oct-10-22 08:00AM
Sep-21-22 08:00AM
Sep-19-22 08:00AM
Sep-17-22 08:36AM
Sep-15-22 04:06PM
04:05PM
Sep-12-22 09:32PM
04:01PM
Sep-09-22 03:10PM
Revance Therapeutics, Inc. is a clinical stage biotechnology company, which engages in the development, manufacturing, and commercialization of novel botulinum toxin products for multiple aesthetic and therapeutic applications. The firm focuses on production of daxibotulinumtoxinA, a botulinum toxin, for aesthetic and therapeutic indications including facial wrinkles and muscle movement disorders. The company was founded by Jacob M. Waugh and L. Daniel Browne on August 10, 1999 and is headquartered in Nashville, TN.
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Jordan Erica Chief Commercial Officer Apr 16 '24 Sale 3.80 2,392 9,096 114,864 Apr 17 04:34 PM Schilke Tobin CFO Mar 18 '24 Sale 5.04 9,361 47,204 192,666 Mar 19 06:44 PM Sjuts Dustin S President Mar 18 '24 Sale 5.04 9,211 46,446 167,550 Mar 19 06:45 PM Moxie Dwight CLO & GC Mar 18 '24 Sale 5.04 8,125 40,971 137,815 Mar 19 06:44 PM Foley Mark J CEO Mar 06 '24 Buy 6.98 30,000 209,400 1,015,468 Mar 08 04:33 PM Moxie Dwight SVP, GC & Secretary Sep 06 '23 Sale 17.06 11,000 187,704 44,066 Sep 07 05:37 PM Moxie Dwight SVP, GC & Secretary Sep 05 '23 Sale 17.81 23,853 424,920 55,066 Sep 07 05:37 PM Foley Mark J CEO Aug 03 '23 Sale 22.57 26,279 593,151 840,375 Aug 04 05:07 PM Foley Mark J CEO Jul 03 '23 Sale 24.94 26,279 655,333 866,654 Jul 05 09:11 PM Schilke Tobin CFO Jul 03 '23 Sale 25.04 1,701 42,593 79,896 Jul 05 09:11 PM Kolaja Carey OConnor Director Jun 15 '23 Option Exercise 18.12 2,500 45,300 19,061 Jun 20 04:25 PM Kolaja Carey OConnor Director Jun 15 '23 Sale 28.24 2,500 70,600 16,561 Jun 20 04:25 PM Foley Mark J CEO Jun 09 '23 Sale 30.72 31,279 960,928 891,933 Jun 13 08:09 PM Sjuts Dustin S President Jun 09 '23 Sale 30.82 5,000 154,096 147,347 Jun 13 08:09 PM Schilke Tobin CFO Jun 02 '23 Sale 31.00 500 15,500 80,828 Jun 05 06:06 PM Schilke Tobin CFO Jun 01 '23 Sale 30.57 2,701 82,570 81,328 Jun 05 06:06 PM Foley Mark J CEO May 15 '23 Sale 34.55 70,447 2,433,725 923,212 May 16 08:29 PM Schilke Tobin CFO May 15 '23 Sale 34.55 21,401 739,338 84,029 May 16 08:29 PM Moxie Dwight SVP, GC & Secretary May 15 '23 Sale 34.55 21,401 739,338 69,165 May 16 08:29 PM Sjuts Dustin S President May 15 '23 Sale 34.55 21,015 726,003 152,347 May 16 08:29 PM
×
Upgrade your FINVIZ experience
Join thousands of traders who make more informed decisions with our premium features.
Real-time quotes, advanced visualizations, backtesting, and much more.
Learn more about FINVIZ*Elite